Odyssey Therapeutics Ownership | Who Owns Odyssey Therapeutics?
Odyssey Therapeutics Ownership Summary
Odyssey Therapeutics is owned by 74.02% institutional investors, 6.07% insiders, and 19.91% retail investors. Fmr is the largest institutional shareholder, holding 10.98% of ODTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.25% of its assets in Odyssey Therapeutics shares.
ODTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Odyssey Therapeutics | 74.02% | 6.07% | 19.91% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 5.18M | 10.98% | $96.90M |
| Sr one capital management, lp | 3.79M | 8.04% | $71.00M |
| Tpg gp a | 3.69M | 7.82% | $69.04M |
| Lightspeed management | 3.61M | 7.65% | $67.51M |
| Orbimed advisors | 3.00M | 6.36% | $56.15M |
| Sanofi | 1.99M | 4.22% | $37.27M |
| Deerfield management company, l.p. (series c) | 1.05M | 2.22% | $19.57M |
| Sands capital ventures | 875.00K | 1.85% | $16.37M |
| Hhlr advisors | 831.66K | 1.76% | $15.56M |
| General catalyst group management | 810.27K | 1.72% | $15.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| General catalyst group management | 810.27K | 8.04% | $15.16M |
| Sanofi | 1.99M | 6.98% | $37.27M |
| Sr one capital management, lp | 3.79M | 6.83% | $71.00M |
| Foresite capital management v | 713.11K | 3.68% | $13.34M |
| Lightspeed management | 3.61M | 2.81% | $67.51M |
| Sands capital ventures | 875.00K | 2.67% | $16.37M |
| Hhlr advisors | 831.66K | 1.87% | $15.56M |
| Catalio capital management, lp | 457.84K | 1.61% | $8.57M |
| Tpg gp a | 3.69M | 1.38% | $69.04M |
| Orbimed advisors | 3.00M | 1.05% | $56.15M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 5.18M | 0.00% | 5.18M |
| Sr one capital management, lp | 3.79M | 6.83% | 3.79M |
| Tpg gp a | 3.69M | 1.38% | 3.69M |
| Lightspeed management | 3.61M | 2.81% | 3.61M |
| Orbimed advisors | 3.00M | 1.05% | 3.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tower research capital llc (trc) | 193.00 | 0.00% | 193.00 |
| Citigroup | 511.00 | - | 511.00 |
| Barclays | 1.46K | - | 1.46K |
| Morgan stanley | 1.77K | - | 1.77K |
| Wells fargo & company/mn | 1.79K | - | 1.79K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Fmr | 5.18M | 0.00% | 5.18M | $96.90M |
| Sr one capital management, lp | 3.79M | 6.83% | 3.79M | $71.00M |
| Tpg gp a | 3.69M | 1.38% | 3.69M | $69.04M |
| Lightspeed management | 3.61M | 2.81% | 3.61M | $67.51M |
| Orbimed advisors | 3.00M | 1.05% | 3.00M | $56.15M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 59 | - | 34,916,655 | - | 74 | - | 59 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 1.08M | 2.25% | 281.40K |
| Fidelity Growth Company Fund | 1.03M | 2.15% | 227.30K |
| Vanguard Morn Total Stk Mkt Idx Investor | 531.10K | 1.11% | 448.20K |
| Vanguard MStar Total Stk Mkt Idx Invest | 531.10K | 1.11% | - |
| HBM Healthcare Investments AG Ord | 507.81K | 1.06% | 507.81K |
| iShares Russell 2000 ETF | 407.98K | 0.85% | 3.50K |
| T. Rowe Price Health Sciences | 373.04K | 0.78% | - |
| Fidelity Select Biotechnology | 339.50K | 0.71% | - |
| Fidelity Growth Company K6 | 288.66K | 0.60% | 63.80K |
| Fidelity Series Growth Company | 249.10K | 0.52% | 54.10K |
ODTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools